•Pfizer's Talzenna and Xtandi combination met the primary endpoint in the Phase III TALAPRO-3 study.
•The study showed significant improvement in radiographic progression-free survival (rPFS) in patients with HRR-mutated metastatic castration-sensitive prostate cancer (mCSPC).
•Pfizer plans to submit the data to global regulatory authorities to support potential label expansion for the treatment.
•Amazon is developing a new smartphone within its devices and services unit under the internal codename "Transformer".
•The device is being positioned as a personalized mobile device that integrates with the Alexa voice assistant to act as a continuous touchpoint for users.
•This marks Amazon's first attempt in the smartphone category since the failure of the Fire Phone more than 10 years ago.
•The Law Offices of Frank R. Cruz announced an investigation into Super Micro Computer, Inc. (SMCI) regarding potential violations of federal securities laws.
•The investigation into SMCI follows a U.S. Justice Department action reported on March 19, 2026.
•Glancy Prongay Wolke & Rotter LLP is continuing its investigation into potential securities law violations by Alibaba Group Holding Ltd. (BABA).
•A securities class action lawsuit was filed against ODDITY Tech (ODD) on behalf of investors who purchased securities between February 2025 and February 2026.
•The company's shares cratered 49% amid reports of a 'dislocation' issue and an expected 30% decline in revenue.
•The law firm Hagens Berman is leading the class action lawsuit to investigate investor misleading.
•The 15-20 National Hospital and GenSight Biologics announced the first patients treated in the French Named Patient Early Access Program (AAC) for LUMEVOQ.
•SELLAS Life Sciences Group (SLS) stock has surged 346% over the past year.
•The company is nearing a critical inflection point in its Phase 3 REGAL trial for a cancer vaccine, with only 8 deaths remaining to reach the clinical endpoint.
•SELLAS is a late-stage clinical biopharmaceutical company focused on immunotherapy for various cancers.
•Lamborghini CEO Stephan Winkelmann stated that disappointing EV charging infrastructure contributed to zero demand for the automaker’s all-electric line.
•Winkelmann described luxury EVs as a 'nonstarter' currently due to these infrastructure hurdles.
•The California Public Utilities Commission (CPUC) conditionally approved a Renewable Natural Gas (RNG) procurement contract from Anaergia's SoCal Biomethane facility.
•This is the first contract to supply under California's SB 1440 program.
•Anaergia is listed on the TSX as ANRG and on the OTCQX as ANRGF.
•The S&P 500 index slipped below its 200-day moving average for the first time in nearly a year, signaling a potential compromise of the long-term uptrend.
•A missile strike on Qatar’s Ras Laffan industrial complex sent energy prices soaring, reigniting fears of a systemic inflationary shock.
•The Fed signaled only one rate cut in 2026, maintaining a hawkish stance that crushed hopes for policy relief.
•US Treasury Secretary Scott Bessent stated Washington may allow 140 million barrels of sanctioned Iranian crude stored on tankers to enter the market.
•Japan’s Nikkei index slid deeper into correction territory amid cautious sentiment in Asian markets.
•Goldman Sachs revised its Bank of England outlook, now expecting rates to be held higher for longer than previously anticipated.
•US DNI Tulsi Gabbard named Pakistan as an emerging missile threat to the US homeland alongside Russia, China, Iran, and North Korea.
•The 2026 Annual Threat Assessment Report cited that Pakistan's long-range ballistic missile development could include ICBMs capable of striking the US.
•Pakistan expressed outrage at being singled out, given its status as a major non-NATO ally since 2004.
